ATC Group: A02BC02 Pantoprazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A02BC02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A02 Drugs for acid related disorders
3 A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4 A02BC Proton pump inhibitors
5 A02BC02 Pantoprazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 40 mg
PAREN - Parenteral 40 mg

Active ingredients in A02BC02

Active Ingredient Description
Pantoprazole

Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells.

Related product monographs

Title Information Source Document Type  
NOLPAZA Gastro-resistant tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
PANTOFLUX Gastro-resistant tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
PANTOLOC CONTROL Gastro-resistant tablet European Medicines Agency (EU) MPI, EU: SmPC
PANTOPRAZOLE 20mg Gastro-resistant tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PANTOPRAZOLE 40mg Gastro-resistant tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PANTOPRAZOLE Powder for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PROTIUM Powder for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
SOMAC CONTROL Gastro-resistant tablet European Medicines Agency (EU) MPI, EU: SmPC
TECTA ฮ•nteric-coated tablets Health Products and Food Branch (CA) MPI, CA: SPM
TOPRAFLUX Enteric coated tablet Health Products Regulatory Authority (ZA) MPI, Generic

Medicines in this ATC group

Australia (AU)

Canada (CA)

Finland (FI)

France (FR)

Israel (IL)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.